Fesoterodine is an antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. A medication used to treat overactive bladder, associated with various conditions such as the sudden urge to urinate.
- Mechanism
- Curator reviewed
Fesoterodine, once converted to its active metabolite, 5-hydroxymethyltolterodine, acts as a competitive antagonists at muscarinic receptors. This results in the inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder.
- Primary indication
- Fesoterodine is indicated for the treatment of overactive bladder in adult patients with symptoms of urge urinary incontinence, urgency, and frequency.Curator reviewed · 2 structured indications
- Formula / weight
- C26H37NO3 · 411.5769 g/mol (avg)
- First approval
- Canada, 2012 · United States, 2008 · European Union, 2016
- Also known as
- FESO
- Brand names
Resolves to
DCCSDBARQIPTGU-HSZRJFAPSA-NSMILESCC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)CWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Fesoterodine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account